Kaya Brands International, Inc. (KBI), an auxiliary of Kaya Holdings Inc (OTCMKTS:KAYS), along with its JV partner – Greekkannabis (GKC) will roll out cannabidiol pet products under the brand – Cannamo in Greece and adjoining nations in Europe.
Involves Day Three Labs
KBI developed the Cannomo brand to satisfy the demand identified by GKC. The company also involved Day Three Labs (DTL), a company based in Israeli, developing the Cannamo brand.
GKC will contribute experience gained in the pet supplement and pet food industry in Greece for the success of this innovative brand. The three partners will play a vital role in introducing the Cannamo brand and facilitating its penetration.
Craig Frank, CEO of Kayak, said the Cannamo brand is a result of the three players’ broader cooperation to establish a large company for global expansion. The three leading players leveraged their strengths in the development and commercialization of the Cannamo brand and make its implementation simple and effective.
Kaya Kannabis, a JV between GKC and Kaya, will nurture relationships with customers for CBD products introduced by the team while rigorous efforts are put in to create a marketing strategy targeted at the EU. Co-founder of GKC, Elias Kammenos, said the launch of CBD pet products will generate revenue streams while a medical cannabis facility is constructed in Greece. It will also familiarize its brands in the EU because plans are underway to introduce THC products.
DTL’s principals – Rafi Cohen and Joshua Robin will be onboard the advisory panel to support the construction of the cultivation and processing project of Kayak in Israel. Craig said the company is excited to work with DTL on mutually beneficial projects. Kayak will benefit from product development and relationships in the scientific cannabis community of Israel.
Long time opportunity
Co-founder of GKC, Panos Kinnis, said their innovative ideas, approach, and vision helped expedite the launch of its products. It also offered a myriad of opportunities to cultivate growth. EU presents a long time demand for cannabidiol and medical cannabis products. GKC plans to go ahead with KBI to take an early lead and capitalize on the emerging opportunities to derive rich dividends.
The Greek government granted a cannabis installation license to GKC to commence Medical Cannabis Cultivation/ processing facility in Thebes, Greece. It will annually produce 225,000 pounds of medical cannabis products. Kayak established KBI to address global markets, leveraging its operational expertise.
Generex Biotechnology Corporation (OTCMKTS:GNBT) Submits Pre-IND For Ii-Key-SARS-CoV-2 Vaccine To The FDA
Post Views: 121 Generex Biotechnology Corporation (OTCMKTS:GNBT) submitted a Pre-IND update to the FDA outlining its proposed Phase I/II clinical...
cbdMD Inc. (NYSEAMERICAN:YCBD) Protecting Its CBD Technologies Through Patents and expands Partnership With Bellator MMA
Post Views: 280 cbdMD Inc. (NYSEAMERICAN:YCBD) announced an extension of the exclusive Official CBD marketing partnership with ViacomCBS’s wholly-owned subsidiary...
CLS Holdings USA Inc (OTCMKTS:CLSH) Increases Revenues In June 2020 By 5.35%
Post Views: 185 CLS Holdings USA Inc (OTCMKTS:CLSH) posted a growth of 5.35% YoY to $1.102 million in June 2020....
Canopy Rivers Inc.’s (OTCMKTS:CNPOF) Portfolio Companies Expanding Their Reach In Canada And The US
Post Views: 238 Canopy Rivers Inc.’s (OTCMKTS:CNPOF) three portfolio companies recently announced plans to expand their product offering for recreational...
AgraFlora Organics International Inc. (OTCMKTS:AGFAF) Processes Around 1,000KG Of CBD Crude Oil From 10,000Kg Of Hemp
Post Views: 304 AgraFlora Organics International Inc. (OTCMKTS:AGFAF) Toronto-based Sustainable Growth Strategic Capital Corp subsidiary in partnership with MicroC45 produced...
Marimed Inc (OTCMKTS:MRMD) Retires $7.3 Million Short-term Debt: Robust Sales Of Adult-Use Programs Improves Cash Flow
Post Views: 171 Marimed Inc (OTCMKTS:MRMD) restructured its debt to provide financial flexibility at reduced interest rates. Marimed replaced the...